Quantcast
Last updated on April 24, 2014 at 11:09 EDT

Latest Retinal Degeneration Stories

2012-03-09 02:37:46

A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States. The pig model was developed by researchers in the University of Louisville Department of Ophthalmology & Visual Sciences and at the National Swine Resource and Research Center at the University of Missouri. "We have previously relied mostly on rodent models to study...

2012-01-23 22:46:02

A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults. The technique works by replacing a malfunctioning gene in the eye with a normal working copy that supplies a protein necessary for light-sensitive cells in the eye to function. The findings are published today (Monday, Jan. 23) in the Proceedings of the National Academy of Sciences online. Several complex and costly steps...

2011-12-13 15:10:32

Research at Wayne State University, Mayo Clinic and Johns Hopkins offers potential treatment for macular degeneration and retinitis pigmentosa Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A collaborative research study among investigators at Wayne State University, the Mayo Clinic and Johns Hopkins Medicine shows that steroids attached to the dendrimers targeted the damage-causing...

2011-12-13 07:00:00

Research at Wayne State University, Mayo Clinic and Johns Hopkins offers potential treatment for macular degeneration and retinitis pigmentosa DETROIT, Dec. 13, 2011 /PRNewswire-USNewswire/ -- Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A collaborative research study among investigators at Wayne State University, the Mayo Clinic and Johns Hopkins Medicine shows that steroids...

2011-10-18 13:54:00

DETROIT, Oct. 18, 2011 /PRNewswire/ -- RetroSense Therapeutics, LLC, a Michigan-based company, announced that it has executed its exclusive, worldwide option and signed a license agreement for novel gene-therapy approaches for treating blindness developed at Wayne State University's School of Medicine. Zhuo-Hua Pan, Ph.D., professor of anatomy and cell biology in the School of Medicine, along with colleagues at Salus University in Pennsylvania, developed the breakthrough therapy and...

2011-10-03 15:24:35

In a paper published in the October 2011 issue of Experimental Biology and Medicine, a team of researchers at Columbia University Medical Center led by Stephen Tsang, MD, Ph.D have achieved temporary functional preservation of photoreceptors in a mouse model for retinitis pigmentosa (RP) using novel bipartite gene therapy. RP is a heterogeneous disorder characterized by progressive degeneration of rod photoreceptors (which mediate night vision) causing night blindness and eventually total...

2011-08-31 20:11:22

New research in the FASEB Journal provides insight into the molecular basis of one form of retinal degeneration, Enhanced S-Cone Syndrome also known as Goldman-Favre Syndrome A new research report published in The FASEB Journal (https://www.fasebj.org) will help ophthalmologists and scientists better understand a rare genetic disease that causes increased susceptibility to blue light, night blindness, and decreased vision called Enhanced S-Cone Syndrome or Goldman-Favre Syndrome. In the...

2011-06-22 14:32:21

RUB Medicine: new protein identified Initially the occurrence of progressive retinal degeneration - progressive retinal atrophy, in man called retinitis pigmentosa - had been identified in Schapendoes dogs. Retinitis pigmentosa is the most common hereditary disease which causes blindness in humans. The researchers report on their findings, in Human Molecular Genetics. Genetic test developed Based on the new findings, the researchers from Bochum have developed a genetic test for diagnosis in...

e13d4010e33afa3cbf67810310576fc3
2011-06-16 07:59:06

Researchers have used cutting-edge stem cell technology to correct a genetic defect present in a rare blinding disorder, another step on a promising path that may one day lead to therapies to reverse blindness caused by common retinal diseases such as macular degeneration and retinitis pigmentosa which affect millions of individuals. In a study appearing in an advance online publication of the journal Stem Cells on June 15, 2011, investigators used recently developed technology to generate...

2011-06-09 23:25:37

Biologists have uncovered a key regulatory mechanism used for gene expression in the visual system. Their findings, which appear in the latest issue of the journal Cell, offer new insights into the complexity behind the genetic make-up of biological systems. The study, which included researchers from New York University's Department of Biology, Japan's Okayama University, Cincinnati Children's Hospital, and Germany's University of Wrzburg, examined the photoreceptor cells in the retina of the...